Posted by Michael Wonder on 19 Aug 2020
Keeping pace with pharmaceutical innovation: the importance of the NICE methods review
19 August 2020 - The NICE plays a vitally important role in ensuring patients get timely access to new medicines that are clinically and cost effective.
The methods used by NICE to appraise medicines (and other health technologies) are currently undergoing extensive review.
As noted by Boysen and Watson, this was an important commitment agreed to in the 2019 Voluntary Scheme for Branded Medicines Pricing and Access.
The review is arguably the most important examination of NICE’s methods in its 20 year history, because the types of new medicines in the pharmaceutical industry pipeline are very different to those seen previously.
